Home6BG • FRA
add
Lytix Biopharma AS
Previous close
€0.44
Day range
€0.45 - €0.45
Year range
€0.41 - €1.11
P/E ratio
-
Dividend yield
-
Market news
Financials
Income Statement
Revenue
Net income
(NOK) | Dec 2023info | Y/Y change |
---|---|---|
Revenue | — | — |
Operating expense | 19.60M | -34.83% |
Net income | -18.58M | 36.36% |
Net profit margin | — | — |
Earnings per share | — | — |
EBITDA | -19.59M | 17.79% |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
(NOK) | Dec 2023info | Y/Y change |
---|---|---|
Cash and short-term investments | 50.55M | -65.18% |
Total assets | 63.44M | -58.27% |
Total liabilities | 12.06M | -28.58% |
Total equity | 51.37M | — |
Shares outstanding | 40.07M | — |
Price to book | 0.34 | — |
Return on assets | -68.27% | — |
Return on capital | -81.46% | — |
Cash Flow
Net change in cash
(NOK) | Dec 2023info | Y/Y change |
---|---|---|
Net income | -18.58M | 36.36% |
Cash from operations | -28.65M | -8.44% |
Cash from investing | 9.86M | 1,512.61% |
Cash from financing | -1.00K | — |
Net change in cash | -18.79M | 30.70% |
Free cash flow | -21.89M | -5.83% |
About
Founded
2003
Website
Employees
7